Thermo Fisher Scientific (TMO) Long-Term Debt Repayments (2009 - 2026)

Thermo Fisher Scientific has disclosed Long-Term Debt Repayments across 16 years of filings, most recently posting $1.4 billion for Q1 2026.

• Quarterly Long-Term Debt Repayments rose 68.5% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 billion (down 32.82% YoY) and the FY2025 annual result came in at $2.4 billion, down 33.13% from the prior year.
• Long-Term Debt Repayments improved to $1.4 billion in Q1 2026, from $787.0 million in the prior quarter.
• Over five years, Long-Term Debt Repayments peaked at $3.8 billion in Q4 2023 and troughed at $375.0 million in Q2 2022.
• A 5-year average of $1.4 billion and a median of $1.0 billion in 2023 frame the typical range for Long-Term Debt Repayments.
• Annual changes were most pronounced in 2022 — Long-Term Debt Repayments slumped 86.62% — and 2026, when it jumped 68.5%.
• Tracing TMO's Long-Term Debt Repayments over 5 years: stood at $375.0 million in 2022, then surged by 908.53% to $3.8 billion in 2023, then tumbled by 33.9% to $2.5 billion in 2024, then slumped by 68.52% to $787.0 million in 2025, then soared by 79.42% to $1.4 billion in 2026.
• Business Quant data shows TMO's Long-Term Debt Repayments at $1.4 billion in Q1 2026, $787.0 million in Q4 2025, and $787.0 million in Q2 2025.